Chao Hong Hu
Keine laufenden Positionen mehr
Vermögen: 90 Mio $ am 31.05.2024
Karriereverlauf von Chao Hong Hu
Ehemalige bekannte Positionen von Chao Hong Hu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Direktor/Vorstandsmitglied | 16.05.2020 | 31.01.2024 |
| Vorstandsvorsitzender | 16.05.2020 | 31.01.2024 | |
| SEAGEN INC. | Corporate Officer/Principal | 01.06.2007 | 01.10.2013 |
| GSK PLC | Corporate Officer/Principal | 01.01.2006 | 01.05.2007 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | 01.01.2005 |
Shanghai Miracogen, Inc.
 Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Vorstandsvorsitzender | 01.01.2014 | - |
| Vorsitzender | 01.01.2014 | - | |
| Gründer | 01.01.2014 | - |
Ausbildung von Chao Hong Hu
| Wuhan University | Undergraduate Degree |
Statistik
International
| China | 4 |
| Vereinigte Staaten | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| GSK PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
- Börse
- Insiders
- Chao Hong Hu
- Erfahrung